Literature DB >> 8505732

Uses and limitations of monoclonal antibodies (MoAbs) in the treatment of malignant disease: a review.

J T Kemshead1, K Hopkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8505732      PMCID： PMC1293954          DOI： 10.1177/014107689308600413

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  22 in total

Review 1.  Transport of molecules across tumor vasculature.

Authors:  R K Jain
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.

Authors:  B Shapiro; J E Copp; J C Sisson; P L Eyre; J Wallis; W H Beierwaltes
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

3.  Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.

Authors:  J M Esteban; D Colcher; P Sugarbaker; J A Carrasquillo; G Bryant; A Thor; J C Reynolds; S M Larson; J Schlom
Journal:  Int J Cancer       Date:  1987-01-15       Impact factor: 7.396

4.  Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.

Authors:  A A Epenetos; A J Munro; S Stewart; R Rampling; H E Lambert; C G McKenzie; P Soutter; A Rahemtulla; G Hooker; G B Sivolapenko
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

5.  Comparison of monoclonal antibody delivery to intracranial glioma xenografts by intravenous and intracarotid administration.

Authors:  Y S Lee; D E Bullard; C J Wikstrand; M R Zalutsky; L H Muhlbaier; D D Bigner
Journal:  Cancer Res       Date:  1987-04-01       Impact factor: 12.701

6.  Therapeutic application of a radiolabelled monoclonal antibody in nude mice xenografted with human neuroblastoma: tumoricidal effects and distribution studies.

Authors:  D H Jones; A Goldman; I Gordon; J Pritchard; B J Gregory; J T Kemshead
Journal:  Int J Cancer       Date:  1985-06-15       Impact factor: 7.396

7.  Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice.

Authors:  A Engert; G Martin; P Amlot; J Wijdenes; V Diehl; P Thorpe
Journal:  Int J Cancer       Date:  1991-09-30       Impact factor: 7.396

8.  131-I coupled to monoclonal antibodies as therapeutic agents for neuroectodermally derived tumors: fact or fiction?

Authors:  J T Kemshead; D H Jones; L Lashford; J Prichard; I Gordon; F Breatnach; H B Coakham
Journal:  Cancer Drug Deliv       Date:  1986

9.  Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.

Authors:  D Colcher; A M Keenan; S M Larson; J Schlom
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

10.  Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia.

Authors:  R O Dillman; D L Shawler; R E Sobol; H A Collins; J C Beauregard; S B Wormsley; I Royston
Journal:  Blood       Date:  1982-05       Impact factor: 22.113
View more
  4 in total

1.  High efficient mammalian expression and secretion of a functional humanized single-chain Fv/human interleukin-2 molecules.

Authors:  Yue-Chun Shen; Xue-Hao Wang; Xiao-Ming Wang; Zao-Lai Chen; Xi-Ping Shen; Chao-Chen Zhao; Jun Li
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

Review 2.  Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics.

Authors:  Timo Rath; Kristi Baker; Jennifer A Dumont; Robert T Peters; Haiyan Jiang; Shuo-Wang Qiao; Wayne I Lencer; Glenn F Pierce; Richard S Blumberg
Journal:  Crit Rev Biotechnol       Date:  2013-10-24       Impact factor: 8.429

3.  Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

Authors:  Vladimir P Torchilin; Anatoly N Lukyanov; Zhonggao Gao; Brigitte Papahadjopoulos-Sternberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

Review 4.  Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.

Authors:  Feng Jiang; Biao Liu; Jun Lu; Fangfei Li; Defang Li; Chao Liang; Lei Dang; Jin Liu; Bing He; Shaikh Atik Badshah; Cheng Lu; Xiaojuan He; Baosheng Guo; Xiao-Bing Zhang; Weihong Tan; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2015-10-09       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.